1-on-1 Meetings Johnson and Johnson Innovation - Chronic Kidney Disease
Opens Jul 21 2021 07:00 AM (GMT)
Deadline Oct 11 2021 11:59 PM (GMT)
Description

Johnson & Johnson Innovation is inviting innovators with potential solutions for Chronic Kidney Disease to apply for the opportunity to be considered for a 1-on-1 meeting. Some of the key potential solutions we are looking for include:

  • Reducing /stopping Albuminuria
  • Repairing kidney structure and function
  • Non-invasive quantification of Renal Fibrosis
  • Identification of fast progressors of the disease
  • New delivery technologies for kidney diseases

Additional areas of interest include unmet needs in:

  • Acute kidney injury
  • Autosomal dominant polycystic kidney disease
  • Focal segmental glomerulosclerosis
  • Nephrotic syndrome
  • gA nephropathy

Meeting the Johnson & Johnson Innovation Team

Companies interested in being considered for an opportunity for a one-on-one virtual meeting need to apply by October 8, 2021 by submitting their non-confidential information. Selected applicants will be invited for a virtual one-on-one meeting with an appropriately matched panel representative. Meetings will take place at mutually convenient times during October and November. Selected companies will receive an invitation by October 23, 2021.

Battling Chronic Kidney Disease Webinar

RSVP to join the Battling Chronic Kidney Disease Webinar on September 28th at 10:15AM PT to hear more from the Johnson & Johnson Innovation team. 

Questions

Please contact Innovation Activation Specialist, Ro Rabanillo Kent, at rrabanil@its.jnj.com

1-on-1 Meetings Johnson and Johnson Innovation - Chronic Kidney Disease


Johnson & Johnson Innovation is inviting innovators with potential solutions for Chronic Kidney Disease to apply for the opportunity to be considered for a 1-on-1 meeting. Some of the key potential solutions we are looking for include:

  • Reducing /stopping Albuminuria
  • Repairing kidney structure and function
  • Non-invasive quantification of Renal Fibrosis
  • Identification of fast progressors of the disease
  • New delivery technologies for kidney diseases

Additional areas of interest include unmet needs in:

  • Acute kidney injury
  • Autosomal dominant polycystic kidney disease
  • Focal segmental glomerulosclerosis
  • Nephrotic syndrome
  • gA nephropathy

Meeting the Johnson & Johnson Innovation Team

Companies interested in being considered for an opportunity for a one-on-one virtual meeting need to apply by October 8, 2021 by submitting their non-confidential information. Selected applicants will be invited for a virtual one-on-one meeting with an appropriately matched panel representative. Meetings will take place at mutually convenient times during October and November. Selected companies will receive an invitation by October 23, 2021.

Battling Chronic Kidney Disease Webinar

RSVP to join the Battling Chronic Kidney Disease Webinar on September 28th at 10:15AM PT to hear more from the Johnson & Johnson Innovation team. 

Questions

Please contact Innovation Activation Specialist, Ro Rabanillo Kent, at rrabanil@its.jnj.com

Opens
Jul 21 2021 07:00 AM (GMT)
Deadline
Oct 11 2021 11:59 PM (GMT)